Challenges in the implementation of ultrasensitive liquid biopsy approaches in precision oncology
J Immunother Cancer
.
2023 Jun;11(6):e006793.
doi: 10.1136/jitc-2023-006793.
Authors
Aakash Desai
1
,
Christine M Lovly
2
Affiliations
1
Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
2
Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA christine.lovly@vumc.org.
PMID:
37349128
PMCID:
PMC10314676
DOI:
10.1136/jitc-2023-006793
No abstract available
Keywords:
Biomarkers, Tumor.
Publication types
Letter
Research Support, N.I.H., Extramural
Comment
MeSH terms
Humans
Liquid Biopsy
Medical Oncology
Neoplasms* / diagnosis
Neoplasms* / pathology
Precision Medicine
Grants and funding
U01 CA224276/CA/NCI NIH HHS/United States
U54 CA217450/CA/NCI NIH HHS/United States
R01 CA227833/CA/NCI NIH HHS/United States
UG1 CA233259/CA/NCI NIH HHS/United States
P01 CA129243/CA/NCI NIH HHS/United States